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Abstract 
The effects of diadenosine pentaphosphate (APsA), and diadenosine hexaphosphate (APtA) on the cytosolic-free Ca 2+ concentration 
([Ca2+]i) were evaluated in cultured human fibroblast cells (HF cells) using the fluorescent dye technique. APsA, and AP6A 
concentration-dependently i creased [Ca 2÷ ]i in HF cells. The addition of 10 /xmol/l APsA and AP6A significantly increased [Ca z+ ]i in 
HF cells from 71 + 3 nmol/1 (n = 184) to 241 +_ 39 nmol/1 (n = 11; P < 0.001 compared to resting value) and to 227 +_ 26 nmol/l 
(n = 23; P < 0.001), respectively. The purinoceptor P2 blockers, suramin and pyridoxal-phosphate-6-azophenyl-2',4'-disulphonic acid 
(PPADS), inhibited the diadenosine polyphophate-induced [Ca2÷ ]i increase, whereas the P2y purinoceptor blocker, reactive blue, had no 
effect. Adenosinetriphosphate (ATP) and the P2x agonist, a,/3-methylene-ATP also significantly increased [Ca ~ ÷ ]i in HF cells, whereas 
the P2y agonist methylthio-ATP showed only a small [Ca2+] i response. Diadenosine polyphosphates mainly induced transplasmamem- 
brane Ca 2÷ influx as was confirmed by experiments in the absence of extracellular Ca 2÷ or by manganese quenching studies. Organic 
(verapamil) and inorganic Ca 2÷ channel blockers (NiC12) significantly reduced the AP6A induced transplasmamembrane Ca 2÷ influx. 
The inhibitor of phosphatidylcholine-specific phospholipase C, D609, significantly reduced the effect of diadenosine polyphosphates on
[ Ca2+ ]i in HF cells. It is concluded that diadenosine polyphosphates regulate transplasmamembrane Ca 2÷ influx after occupation of P2x 
receptors via activation of phosphatidylcholine-specific phospholipase C and hence of voltage-operated Ca2÷ channels. 
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1. Introduction 
Biological responses to extracellular adenine nu- 
cleotides include increases in membrane permeability, 
stimulation of exocrine and endocrine secretion, relaxation 
or contraction of smooth muscles, platelet aggregation, and 
modulation of neural excitability [1,2]. Recently novel 
vasoconstrictor agents, diadenosine pentaphosphate (AP 5 A) 
and diadenosine hexaphosphate (AP 6 A) have been isolated 
Abbreviations: APsA, diadenosine pentaphosphate; APtA, diadeno- 
sine hexaphosphate; [Ca 2+ ]i, cytosolic-free Ca 2+ concentration; HF 
cells, human fibroblast cells; D609, phosphatidylcholine-specific 
phospholipase C inhibitor; DPCPX, dipropylcyclopentylxanthine; DMPX, 
dimethylpropylxanthine; PPADS, pyridoxal-phosphate-6-azophenyl- 
2',4'-disulphonic acid; a,/3-methylene-ATP, ot,/3-methylene-adenosine 
triphosphate; methylthio-ATP, methylthio-adenosine triphosphate 
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from human platelets [3]. Both AP~A and APtA increased 
the systemic blood pressure in rats [3]. APsA and APtA 
have also been shown to stimulate growth in glomerular 
mesangial cells [4] and to be released by platelet aggrega- 
tion [5]. Therefore, both agents may contribute to the 
development of glomerulosclerosis. 
In this context, the effects of APsA and AP6A on 
fibroblasts are also of interest, but have not yet been 
studied in detail. In the present study, it was examined 
whether and how human fibroblasts are stimulated by 
APsA and APtA. Moreover, our knowledge on the respon- 
siveness of human tissue to diadenosine polyphosphates 
still needs to be amplified, since up to now only human 
umbilical cord arteries are known to be contracted by 
APsA and AP6A [6]. The results of the present study 
indicate that human fibroblasts are responsive to AP 5 A and 
AP 6 A and that stimulation of fibroblasts by these diadeno- 
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sine polyphosphates is mediated partly by P2x purinocep- 
tors and partly by suramin-insensitive diadenosine 
polyphosphate r ceptors. 
2. Materials and methods 
2.1. Cell culture 
Human fibroblasts (HF cells) were obtained from 
healthy subjects and cultured by the tissue explant method. 
Briefly, cells were incubated in Dulbecco's modified Ea- 
gle's medium (Gibco, Eggenstein, Germany), containing 
10% (v/v)  fetal calf serum (Boehringer, Mannheim, Ger- 
many), 100 U/ml  penicillin G and 100 /zg/ml strepto- 
mycin. Cultures were incubated at 37°C in a humidified 
atmosphere of 95% air and 5% CO 2. The medium was 
changed initially after 24 h and then every 2-3 days. After 
the first subculture, cells were subcultured every week at a 
seeding density of about 1 • 10 4 cells/cm 2 and reached 
confluence in 8 to 10 days. Thereafter they were harvested 
by adding 0.05% trypsin, and the culture was continued up 
to 8 passages. 
It was confirmed that cultured HF cells were free from 
contamination with endothelial cells. A viability of HF 
cells higher than 95% was observed by trypan blue exclu- 
sion. Cells were made quiescent by incubation in serum- 
free medium containing 0.1% bovine serum albumin, 100 
U/ml penicillin and 100 /~g/ml streptomycin for 48 h 
prior to measurements of cytosolic-free Ca 2+ concentra- 
tion ([Ca 2+ ]i). 
2.2. Measurement of  cytosolic-free Ca 2÷ concentration 
([Ca2 + ]i ) in HF cells 
Measurements of [Ca2+] i were performed using the 
Ca2+-sensitive dye 1-[2-(5-carboxyoxazol-2-yl)-6-amino- 
benzofuran-5-oxyl]-2-(2'-amino-5'-methylphenoxy)-ethane- 
N,N,N'N'-tetra-acetic acid, pentaacetoxymethylester 
(fura2/AM) as described by Grynkiewicz et al. [7] and 
Williams et al. [8] using HF cells grown on round cover- 
slips with a diameter of 13 mm. HF cells on cover slips 
(2.5.104 cells/cover slip) were washed twice in physio- 
logical salt solution (PSS, containing in mmol/l: NaC1 
135, KCI 5, CaC12 l, MgC12 1, D-glucose 5.5, N-2-hy- 
droxyethyl-piperazine-N'-2-ethanesulfonic acid (Hepes) 10, 
pH 7.4) and then incubated with 10 /zmol/1 cell-permeant 
fura2/AM and 0.02% (w/v)  nonionic surfactant poly- 
oxypropylenepolyoxyethylene block copolymer, pluronic 
F-127 (Molecular Probes, Eugene, OR), for 60 minutes at 
37°C. After loading of the cells with fura2/AM the experi- 
ments were continued only when a viability higher than 
95% was observed by trypan blue exclusion. At the end of 
the loading period, the coverslips were washed twice in 
PSS and inserted into quartz glass cuvettes with 2 ml PSS. 
The fluorescence intensity of fura2-1oaded HF cells was 
measured at 37°C using a spectrofluorophotometer RF-5001 
PC (Shimadzu, Tokyo, Japan) The fluorescence of fura2 
was measured using a data sampling interval of 1 s with 
alternate xcitation wavelengths of 340 nm and 380 nm 
(bandwidth, 5 nm), and emission was collected at 510 nm 
(bandwidth, 5 nm). Autofluorescence was measured in 
similar cells which had not been loaded with fura2- 
acetoxymethylester and was less than 5% of the total 
fluorescence of fura2 loaded HF cells. After the subtrac- 
tion of autofluorescence foreach wavelength, the ratio (R) 
of the measured fluorescence values at 340 nm and 380 
nm excitation was calculated [7,8]. The F340 nm/F380 nm 
excitation ratio of resting HF cells remained constant 
during the whole experiment, indicating a stable resting 
[ Ca2+ ]i in HF cells. As indicated by control experiments 
no significant spontaneous increase of resting [Ca 2+ ]i could 
be observed uring the measurements. Calibration of the 
fluorescence signal in terms of [Ca2+]i was performed 
with digitonin and ethylene glycol-bis-(/3-aminoethyl 
ether)-N,N,N'N'-tetraacetic a id (EGTA) at each cover 
slip. 1 mmol/1 digitonin and 5 mmol/ l  EGTA were 
sequentially added to determine the maximum (Rma x) and 
the minimum (gmi n) of the F340 nm/ /F380 nm excitation 
ratio, respectively. Control experiments confirmed that 
further increase of the digitonin or EGTA concentration 
had no effect on Rma x or Rmin, respectively. The minimal 
fluorescence excitation ratio was 0.99 + 0.01 and the max- 
imal fluorescence excitation ratio was 2.77 + 0.11. [Ca 2÷ ]i 
was calculated according to Grynkiewicz et al. with a 
dissociation constant of fura2 for Ca 2÷ of 224 nmol/l  [7]. 
Leakage during the measurement was less than 5% of the 
total fluorescence as observed by quenching of external 
fluorescence with 100 /zmol/1 MnC12 as described else- 
where [9]. 
Since the purinoceptor P2 blocker suramin may inter- 
fere with the fura2 fluorescence additional experiments 
were carried out using the calcium-sensitive fluorescent 
dye fluo3 (Sigma) using an excitation wavelength of 490 
nm and an emission wavelength of 525 nm when suramin 
was used. 
2.3. Ca 2 + influx measurements u ing MnCl 2 
To measure Mn 2+ influx as a reporter of unidirectional 
Ca 2+ influx, the entry of Mn 2+ into HF cells was evalu- 
ated using the fura2 quenching technique [10]. HF cells 
were loaded as for [Ca2+] i measurements and fura2 fluo- 
rescence monitored in a Ca 2+ containing medium at the 
Ca z+ insensitive xcitation wavelength 360 nm. Then, 0.5 
mmol/ l  MnC12 was added, and its entry into HF cells was 
measured as the rate of fluorescence decrease. 
2.4. Purification of  the diadenosine phosphates AP 5 A and 
AP6 A 
As, both APsA and APtA showed impurities in com- 
mercially available preparations, both agents were only 
used after purification with HPLC [4]. 
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Diadenosine pentaphosphate (APsA) and diadenosine 
hexaphosphate (AP6A), adenosine triphosphate (ATP), 
a,fl-methylene-ATP, verapamil, the phosphatidylcholine- 
specific phospholipase C inhibitor, tricyclodecan-9-yl xan- 
thogenate (D609), and all other substances were purchased 
from Sigma Chemical Co. (Deisenhofen, Germany) if not 
indicated otherwise. The purinoceptor P2 blockers, 
suramin, and pyridoxal-phosphate-6-azophenyl-2',4'-dis- 
ulphonic acid (PPADS), the purinoceptor P2y blocker, 
reactive blue, the P2y receptor agonist, methylthio-ATP, 
the adenosine A1 receptor blocker, dipropylcyclopentylx- 
anthine (DPCPX), and the adenosine A2 receptor antago- 
nist, dimethylpropylxanthine (DMPX), were purchased 
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Fig. 2. Concentration-reponse curve of diadenosine pentaphosphate 
(APsA; open circles) and diadenosine hexaphosphate (AP6A; filled cir- 
cles)-induced increase of cytosolic-free Ca 2+ concentration ([Ca 2+ ]i) in 
cultured human fibroblast cells (HF cells). APsA or AP6A were added to 
fura2-1oaded HF cells and the peak [Ca 2+ ]i increase was determined. 
Values represent the mean + SEM. 
2.5. Statistics 
All data are presented as mean + SE. For statistical 
evaluation of the data Wilcoxon' s test was used. Two-tailed 
P values less than 0.05 were considered to be significant. 
Original tracings shown in the figures are representative 
for at least 5 separate xperiments. 
3. Results 
3.1. Effect of diadenosine polyphosphates on [Ca 2 +]i in 
HF cells 
were 0.58 /zmol/1 and 0.29/xmol/l  for AP5A and AP6A, 
respectively. The addition of 10 /xmol/l APsA and AP6A 
significantly increased [Ca2+]i in HF cells to 241 + 39 
nmol/1 (n = 11; P < 0.001 compared to resting value) 
and to 227 + 26 nmol/ l  (n = 23; P < 0.001), respectively. 
HF were subcultured up to the 8th passage. The AP 6 A-in- 
duced [Ca 2÷ ]i increase was not significantly different be- 
tween different subcultures. The [Ca2+] t increase induced 
by 10 /zmol/1 AP6A was 221 + 46 nmol/ l  in HF cells 
from passage 2 and it was 196 + 32 nmol/1 in passage 8
(n.s.). The sustained [Ca2÷]i after the administration of 
APsA and AP6A were 182+44 nmol/1 (n= 11, P< 
0.001) and 170 _ 18 nmol/ l  (n = 23, P < 0.001). 
Resting [Ca2+] i in HF cells was 71 +_ 3 nmol/1 (n = 
184). The administration of diadenosine polyphosphates 
increased [Ca2+] i in HF cells. As shown in Fig. 1, the 
addition of APsA and AP6A instantly increased [Ca2+] i,
reaching a peak concentration after about 30 to 50 s. 
Thereafter the [Ca2+] i declined slowly, reaching a sus- 
tained [Ca 2÷ ]i level above the resting value. As shown in 
Fig. 2, the administration of diadenosine polyphosphates 
increased [Ca 2+ ]i in HF cells in a concentration-dependent 
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Fig. 1. Effect of diadenosine pentaphosphate (APsA) and diadenosine 
hexaphosphate (AP6A) on cytosolic-free Ca z+ concentration ([Ca 2÷ ]i) in 
cultured human fibroblast cells (HF ceils). HF cells were loaded with the 
fluorescent dye fura2 and [Ca 2+ ]i was  determined spectrophotometri- 
cally. At the indicated time 10 /xmol/1 APsA or AP6A were added, 
respectively. The figure shows representative tracings out of 11-23 
similar experiments. 
3.2. Diadenosine polyphosphates induce Ca 2 ÷ influx 
In order to evaluate whether the diadenosine polyphos- 
phate-induced [Ca2+]i increase is due the transplas- 
mamembrane Ca 2÷ influx, experiments were conducted in 
the absence of external Ca 2+ or using the manganese 
quenching technique. In the absence of external Ca 2÷ the 
administration of 10 /.tmol/1 APsA and AP6A did not 
significantly change [Ca 2÷ ]i in HF cells (57 _ 11 nmol/1, 
n = 5; and 37 + 4 nmol/l, n = 4), indicating that the 
diadenosine polyphosphate-induced [Ca 2+ ]i increase in the 
presence of external Ca 2+ was due to a transplasmamem- 
brane Ca 2+ influx. In additional experiments Mn 2÷ influx 
was measured as a reporter of unidirectional Ca 2÷ influx. 
As shown in Fig. 3, the administration of 10 /xmol/l 
AP 6 A produced a rapid decrease of fura2 fluorescence due 
to transplasmamembrane Mn 2+ influx. Similar results 
could be obtained with APsA. These findings support he 
view that diadenosine polyphosphates nhance the Ca 2÷ 
entry into HF cells. 
3.3. Effect of purinoceptor blockers on diadenosine 
polyphosphate-induced [Ca 2 ÷ ]i increase 
Next the question arises whether the [Ca 2 ÷ ]i increase in 
HF cells induced by diadenosine polyphosphates is medi- 
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Fig. 3. Original tracing showing the diadenosine hexaphosphate (AP6A)- 
induced Mn 2+ entry into cultured human flbroblast cells (HF cells) as 
measured by fura2 quenching. 10 /.Lmol/1 APsA were added to fura2 
loaded HF cells in the presence of Mn 2+ and the fluorescence was 
measured at the Ca 2+ insensitive xcitation wavelength of 360 nm. The 
tracing indicating the reduction of intracellular fura2 fluorescence due to 
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Fig. 5. Effect of adenosine receptor antagonists or calcium channel 
blockers on diadenosine hexaphosphate (AP6A) induced increase of 
cytosolic-free calcium concentration ([Ca 2+ ]i) in cultured human fibrob- 
last cells (HF cells). The adenosine A1 receptor antagonist, dipropylcy- 
clopentylxanthine (DPCPX), the adenosine A2 receptor antagonist, 
dimethylpropylxanthine (DMPX), the organic calcium channel blocker, 
verapamil, or the inorganic alcium channel blocker, NiC12, were added 
prior to the administration f 10/zmol/1 AP6A. Data represent the mean 
+ SEM of the [Ca 2+ ]i increase after administation of AP6A from 5 to 
23 experiments. * * P < 0.01 compared to control conditions (open bar). 
ated by purinergic receptors. The AP6A-induced [Ca2÷] i 
increase was decreased after administration of the 
purinoceptor P2 blockers, suramin (Fig. 4) or PPADS, 
indicating that the effects of AP 6 A may partly be transmit- 
ted by purinergic P2 receptors. Suramin reduced the 
AP6A-induced peak [Ca2+]i f rom 227___26 nmol/1 to 
102 ___ 20 nmol/1 (n = 5; P < 0.01). To avoid any interfer- 
ence of suramin with the fluorescent dye we loaded HF 
cells with the calcium-sensitive fluorescent dye fluo3 when 
suramin was used. Under these conditions it was con- 
firmed that the purinoceptor P2 blocker suramin reduced 
the AP6A induced [Ca2+]i increase in HF cells. PPADS 
reduced the AP6A-induced peak [Ca2+] i f rom 227 + 26 
nmol/1 to 155 + 33 nmol/1 (n = 5). On the other hand, 
the inhibition of purinergic P2y receptors by reactive blue 
did not significantly reduce the AP 6 A-induced peak [Ca 2÷ ]i 
(284 + 50 nmol/1, n = 5, P = 0.238). 
3.4. Effect of adenosine receptor blockers on diadenosine 
polyphosphate-induced [Ca e ÷ ]i increase 
The adenosine A 1 receptor blocker, DPCPX, did not 
significantly reduce the [Ca 2÷ ]i increase induced by APsA 
or AP6A. Similarly, the adenosine A 2 receptor antagonist, 
DMPX, did not significantly reduce the AP6A-induced 
[Ca2+] i increase in HF cells (Fig. 5). DPCPX or DMPX 
had no effect on the sustained [Ca 2÷ ]i increase after the 
addition APsA or AP6A. 
3.5. Effect of calcium antagonists on diadenosine 
polyphosphates induced [Ca e + ]i increase 
The Ca 2÷ channel blockers verapamil (final concentra- 
tion: 10/zmol/ l)  or NiCI 2 (final concentration: 6 mmol/1) 
significantly reduced the peak [Ca 2 ÷ ]i after AP 6 A adminis- 
tration (Fig. 5). Verapamil and NiCI 2 significantly reduced 
the sustained [Ca2÷]~ in HF cells after addition of AP6A 
from 170 +_ 18 nmol/ l  (n = 23) to 77 +_ 11 nmol/ l  (n = 5, 
P < 0.01) or to 53 _+ 11 nmol/1 (n -- 5, P < 0.01), respec- 
tively. These experiments indicate that voltage operated 
Ca 2+ channels may be involved in the diadenosine 
polyphosphate induced transplasmamembrane Ca 2 + influx. 
3.6. Inhibition of the phosphatidylcholine-specific 
phospholipase C reduces the diadenosine polyphosphates 
induced [Ca 2 + ]i increase 
After administration of the phosphatidylcholine-specific 






Fig. 4. Original tracing showing the effect of suramin (100 /zmol/1) on 
diadenosine hexaphosphate (AP6A)-induced increase in cytosolic-free 
Ca 2+ concentration ([Ca 2+ ]i) in cultured human fibroblast cells (HF 









Fig. 6. Effect of the phosphatidylcholine-specific phospholipase C in- 
hibitor, D609, on diadenosine hexaphosphate (AP 6 A)-induced increase in 
cytosolic-free Ca 2+ concentration ([Ca 2+ ]i) in cultured human fibroblast 
ceils (HF cells). Original tracings are representative of 5 similar experi- 
ments. 
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[ Ca2 + ]i increase was significantly reduced from 227 + 26 
nmol/ l  to 112_27 nmol/1 (n=5,  P<0.01)  and the 
sustained [Ca2+] i increase was reduced from 170+__ 18 
nmol/1 (n = 23) to 62 +__ 21 nmol/1 (Fig. 6, n = 5, P < 
0.01). These experiments indicate that the transplas- 
mamembrane Ca 2÷ influx subsequent to the administration 
of diadenosine polyphosphates is mediated by phospho- 
lipase C. 
In addition, the effects of ATP and a, fl-methylene-ATP 
on [Ca2+]i in HF cells were studied. 10 /xmol/l ATP 
significantly increased [Ca2÷]i in HF cells to 451_+91 
nmol/1 (n = 9, P < 0.001 compared to control value), and 
the sustained [Ca2+]i was 260_+ 57 nmol/1. (n---9, P < 
0.01). In the presence of suramin the ATP-induced peak 
[Ca2+]i was significantly reduced to 143 +__ 26 nmol/ l  
(n---5, P < 0.02) and the sustained [Ca2+]i was reduced 
to 124 + 28 nmol/ l  (Fig. 5, n = 5). The purinoceptor P2x 
agonist, a,/3-methylene-ATP, significantly increased 
[ Ca2+ ]i in HF cells to 163 +_ 30 nmol/1 (n = 5, P < 0.01), 
and the sustained [Ca2+]i was 160___ 33 nmol/ l  (n = 5, 
P < 0.01). The purinoceptor P2y agonist, methylthio-ATP, 
showed a small [Ca2+]i increase (peak [Ca2+]i 110 + 14 
nmol/1, n = 5, P < 0.05), whereas the sustained [Ca2+]i 
was 81 + 10 nmol/1 (n = 5). 
To further examine the interactions between ATP and 
APsA or AP6A on [Ca2+]i, either APsA or AP6A were 
administered after preincubation with 10 txmol/1 ATP. 
Under these conditions both diadenosine polyphosphates 
induced a further [Ca 2+ ]i increase (APsA: [Ca 2+ ]i increase 
63 +_ 11 nmol/l, n = 5; APrA: [Ca2+] i increase 57 ___ 15 
nmol/l, n = 5). 
4. Discussion 
The present findings demonstrate that diadenosine 
polyphosphates induce a Ca 2+ influx in HF cells. The 
effects of diadenosine polyphosphates on HF cells were 
studied firstly, to evaluate whether also fibroblasts, besides 
mesangial cells [4] and vascular smooth muscle cells [3], 
respond to diadenosine polyphosphates, and secondly, to 
test the responsiveness of a further human cell type to 
diadenosine polyphosphates. 
The experiments how that the increase in [Ca2+]i 
induced by diadenosine polyphosphates is almost exclu- 
sively due to a transplasmamembrane Ca 2÷ influx, whereas 
Ca 2÷ release from cellular stores does not appear to be 
involved in diadenosine polyphosphate-induced changes of 
[Ca2+]i in HF cells. In other cell types, diadenosine 
polyphosphates also elicit a release of intracellular stored 
Ca 2+ [11,12]. 
The experiments with organic and inorganic Ca 2÷ chan- 
nel blockers indicate that the diadenosine polyphosphate- 
induced Ca 2+ influx may not exclusively be mediated by 
voltage-dependent L-type Ca 2+ channels. Interestingly, a 
considerable portion of the diadenosine polyphosphate-in- 
duced Ca 2÷ influx was insensitive to organic and inor- 
ganic Ca 2+ channel blockers. This finding is consistent 
with the concept hat Pzx receptors represent a non-selec- 
tive cation channel activated by nucleotides, which is 
distinct from the L-type Ca 2+ channel [13]. 
The response of HF cells to APsA and AP6A is partly, 
but not entirely mediated by P2x purinoceptors. In the 
experiments with the unspecific P2 purinoceptor blocker, 
suramin, and with the specific P2x purinoceptor blocker, 
PPADS, a significant portion of the [Ca 2÷ ]i response was 
insensitive to purinoceptor blockade. Pintor and Miras 
Portugal recently demonstrated a novel diadenosine 
polyphosphate r ceptor in rat brain synaptosomes, which, 
unlike to the known P2 purinoceptors, is insensitive to 
suramin [14]. Therefore it may be speculated that also in 
human fibroblasts this diadenosine polyphosphate r ceptor 
may be activated. Although hitherto this receptor cannot be 
characterized using a specific blocker, the activation of 
such a receptor is the most likely explanation of the partial 
insensitivity of the diadenosine polyphosphate r sponse to 
P2 purinoceptor blockers. 
Besides specific diadenosine polyphosphate r ceptors, 
also P2x purinoceptors mediate the diadenosine polyphos- 
phate response in HF cells, as evidenced by the inhibitory 
effects of suramin and PPADS. Furthermore, ATP and 
a,/3-methylene ATP, but not the P2y purinoceptor agonist 
elicited a similar response. Furthermore, the diadenosine 
polyphosphates tested and ATP at least partially activate 
different receptors, ince the administration of diadenosine 
polyphosphates after preincubation with a maximally ef- 
fective concentration of ATP yielded a further [Ca2+]i 
increase. This finding also makes the hypothesis unlikely, 
that diadenosine polyphosphates xert their action through 
their degradation products uch as ATP. 
The experiments further allow some speculations on the 
signaling events downstream to the receptor. Firstly the 
findings suggest that the phosphatidylcholine-specific 
phospholipase C be involved. Since this enzyme is known 
to produce diacylglycerol and phosphorylcholine, which 
are known to modulate Ca 2+ influx, this finding fits well 
with the results showing the predominant role of Ca 2÷ 
influx for the [Ca 2 ÷ ]i response. 
In summary, the study demonstrates that APsA and 
AP6A stimulate human fibroblasts as shown by the [Ca 2÷ ]i 
response. The [Ca 2+ ]i increase is partly P2x purinoceptor- 
mediated and may partly be due to activation of a specific 
diadenosine polyphosphate r ceptor. As both agents are 
released by platelet aggregation [5], possibly APsA and 
AP6A play a role in local stimulation of fibroblasts and 
hence may modulate fibrotic processes. 
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